Quality of life, impotence, and activity level in a randomized trial of immediate repair versus surveillance of small abdominal aortic aneurysm  by Lederle, Frank A et al.
Quality of life, impotence, and activity level in a
randomized trial of immediate repair versus
surveillance of small abdominal aortic aneurysm
Frank A. Lederle, MD,a Gary R. Johnson, MS,b Samuel E. Wilson, MD,c Charles W. Acher, MD,d David
J. Ballard, MD, PhD,e Fred N. Littooy, MD,f Louis M. Messina, MD,g for the Aneurysm Detection and
Management Veterans Affairs Cooperative Study, Minneapolis, Minn; West Haven, Conn; Orange, Calif;
Madison, Wis; Dallas, Tex; Maywood, Ill; and San Francisco, Calif
Objective: We compared long-term health-related quality-of-life outcome after randomization to immediate elective repair
or imaging surveillance, and in relation to time of elective repair, in patients with small asymptomatic abdominal aortic
aneurysm (AAA).
Methods: This randomized clinical trial was carried out in 16 Veterans Affairs medical centers. Study subjects were patients
at good surgical risk, aged 50 to 79 years, with AAAs 4.0 to 5.4 cm in diameter. Interventions included immediate open
surgical AAA repair or imaging surveillance every 6 months with repair reserved for AAAs that became symptomatic or
enlarged to 5.5 cm. Main outcome measures considered were SF-36 health status questionnaire, prevalence of impotence,
and maximum activity level, which were determined at randomization and at all follow-up visits.
Results: Eleven hundred thirty-six patients were randomized and followed up for 3.5 to 8 years (mean, 4.9 years). The two
randomized groups did not differ significantly for most SF-36 scales at most times, but the immediate repair group scored
higher overall in general health (P < .0001), which was particularly evident in the first 2 years after randomization, and
slightly lower in vitality (P < .05). The baseline value of one SF-36 scale, physical functioning, was an independent
predictor of mortality. Overall, more patients became impotent after randomization to immediate repair compared with
surveillance (P < .03), but this difference did not become apparent until more than 1 year after randomization. Maximum
activity level did not differ significantly between the two randomized groups, but decline over time was significantly
greater in the immediate repair group (P < .02).
Conclusions: For most quality-of-life measures and times there was no difference between randomized groups. Immediate
repair resulted in a higher prevalence of impotence more than 1 year after randomization, but was also associated with
improved perception of general health in the first 2 years. (J Vasc Surg 2003;38:745-52.)
Each year in the United States more than 30,000
patients undergo elective repair of asymptomatic abdomi-
nal aortic aneurysm (AAA).1 The purpose of elective AAA
repair is to prevent future rupture. Risk for rupture in-
creases with AAA diameter, but the optimal AAA diameter
at which to offer elective repair has been the subject of
extensive debate. Recently two randomized trials compared
immediate elective repair with surveillance for small asymp-
tomatic AAAs and found that repair of AAAs smaller than
5.5 cm does not improve survival.2,3 We report health-
related quality-of-life outcome during one of these trials,
the Aneurysm Detection and Management (ADAM) Study
(Veterans Affairs Cooperative Study No. 379).3
METHODS
Details of the ADAM study design have been published
previously3,4 and are briefly reviewed here. Eligible patients
were 50 to 79 years of age, had AAAs 4.0 to 5.4 cm in
diameter on centrally read computed tomography scans
within 12 weeks before randomization, and had neither
previous aortic surgery or probable need for aortic surgery
(other than abdominal aneurysm repair) within the next 6
months, evidence of AAA rupture, recent rapid AAA expan-
sion, suprarenal or juxtarenal aneurysm or known large
thoracic aneurysm, severe heart, lung, liver, or renal disease,
recent major surgery or angioplasty, expected survival less
than 5 years, probable noncompliance, severe debilitation,
nor inability to give informed consent.
Patients were recruited over 5 years at 16 Veterans
Affairs medical centers and randomized to immediate open
surgical repair or surveillance. In the immediate repair
group, standard open repair was to be performed within 6
weeks of randomization. In the surveillance group, AAA
was measured with ultrasonography or computed tomog-
raphy every 6 months and repair was deferred until the AAA
was 5.5 cm in diameter or larger or symptoms of rupture
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developed. Study nurses collected interim history and ques-
tionnaire data on all patients before randomization and at
clinic visits scheduled every 6 months thereafter during the
8-year study. Patients in the surveillance group with unre-
paired AAA underwent AAA imaging and measurement at
these visits. Telephone interviews were conducted if pa-
tients failed to attend clinic visits. For analysis, actual visits
were assigned to the closest scheduled time.
We have reported the primary outcome of total mor-
tality3; here we report quality-of-life outcome. General
health status was measured with the SF-36, a brief ques-
tionnaire derived from the Medical Outcomes Study,
which has been extensively tested and used in numerous
research projects.5 The SF-36 evaluates eight health dimen-
sions: physical functioning, role limitations due to physical
problems, social functioning, bodily pain, general mental
health, role limitations due to emotional problems, vitality,
and general health perceptions. These have been aggre-
gated into two summary measures, a physical component
summary and a mental component summary.5 SF-36
health status questionnaires were completed by the patient
and reviewed for completeness by the study nurse. Also at
each visit, patients were asked by the study nurse to rate
their sexual function as normal, impotent, retrograde ejac-
ulation, or other, and to rate their maximum activity level as
sedentary, mild activity, moderate activity, or vigorous
activity. The study nurse was available to further explain the
questions as needed.
All data were entered twice and checked with computer
algorithms. Comparison of randomized groups was by
intent to treat. P values are for two-tailed tests. Indepen-
dent predictors of mortality were evaluated with forward
stepwise regression. Some SF-36 scores include imputation
for missing responses, according to the standard scoring
algorithm.6 Responses to the SF-36 were treated as contin-
uous variables, and were compared between treatments and
between follow-up visits, with unpaired and paired t tests,
respectively. Treatment effect and change in SF-36 re-
sponse over time were also assessed in repeated measures
models, assuming unstructured covariance and using treat-
ment assigned and baseline measurements as covariates
(SAS PROC MIXED; SAS Institute, Cary, NC).
The prevalence of impotence at each visit was the
number of “impotent” responses divided by the total num-
ber of responses. A general estimating equation model
(SAS PROC GENMOD; SAS) was used to assess treatment
effect of repeated measures. Impotence rate was compared
between treatments at individual time points with the 2
test, and the direction and magnitude of within-patient
changes between visits was assessed with the McNemar test
for symmetry. An overall trend in impotence (unadjusted
forwithin-patient changes)wasdeterminedwith theCochran-
Armitage test for trend.7
Maximum activity level was treated as an ordinal re-
sponse variable, and within-visit treatment comparisons
were made with the Wilcoxon rank sum test.8 Paired com-
parisons between visits and before and after AAA repair
were performed with the Wilcoxon signed rank test for shift
in distribution.8 A repeated measures model assuming un-
structured covariance was used to analyze the change in
activity level over time. The “before repair” value shown for
prevalence of impotence and for maximum activity level is
the last value obtained before AAA repair, with the next
value assigned as 6 months after repair.
RESULTS
Five hundred sixty-nine patients were randomized to
the immediate repair group, and 567 were randomized to
imaging surveillance. Patient characteristics at baseline have
been reported.3 Mean patient age was 68 years, 99% of
patients were men, and 94% of patients were white. The
two groups did not differ significantly at randomization in
mean values of any of the SF-36 scales, prevalence of
impotence, mean maximum activity levels, or any other
characteristics, except for a previously reported small differ-
ence in serum creatinine level.3
Patients were followed up for 3.5 to 8 years (mean, 4.9
years). All AAAs were asymptomatic at baseline and at all
routine follow-up visits, during which quality of life data
were collected. By the end of the study, AAA repair had
been performed in 92.6% of the immediate repair group
(72.1% within 6 weeks after randomization) and 61.6% of
the surveillance group. As reported,3 143 patients in the
immediate repair group died, compared with 122 patients
in the surveillance group (relative risk for immediate repair
group, 1.21; 95% confidence interval [CI], 0.95-1.54).
There were 19 AAA-related deaths in each group (relative
risk for immediate repair group, 1.03; 95% CI, 0.54-
1.94).9 Eighty-five percent of follow-up visits were com-
pleted in the immediate repair group, and 87% in the
surveillance group (P  .02).3 Responses for specific qual-
ity of life outcome were missing in fewer than 0.5% of
completed visits; exact numbers are given in the figures.
SF-36 questionnaires were obtained later for some missed
visits, resulting in slightly higher numbers.
SF-36 scores for the two groups are shown in Fig 1. All
SF-36 scales showed significant decrease over time for the
entire study population (P  .001). There was no signifi-
cant difference between the two groups after randomiza-
tion for most SF-36 scales, but the general health score was
significantly higher in the immediate repair group at re-
peated measures analysis (P  .0001). This overall differ-
ence was reflected in significantly higher scores (P .05) at
individual time points from 6 months to 2 years. Repeated
measures analysis also indicated a small difference in vitality
favoring the surveillance group (P  .05). Several other
time point comparisons were nominally significant (P 
.05), but should be interpreted with caution because of the
large number of comparisons. These included better scores
in the immediate repair group at 6 months in mental health,
and worse scores at 5 years in physical functioning and at
6.5 years in role—physical. The baseline value of one SF-36
scale, physical functioning, was an independent predictor of
mortality during the trial.
Impotence was reported by more than a third of pa-
tients at randomization (Fig 2). Overall, at repeated mea-
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Fig 1. Mean SF-36 scores by treatment group. All scores are 0 to 100, with 100 representing better health. Asterisks
at individual time points represent P .05. See text for overall differences. Black circles, Immediate repair group; open
circles, surveillance group.
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Fig 2. Prevalence of impotence by treatment group. Overall, at repeated measures analysis, impotence was significantly
increased after randomization in immediate repair group (P  .03).
Fig 3. Prevalence of impotence in all study patients who underwent AAA repair. “New” impotence is not shown before
repair, because there was no previous record for comparison.
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sures analysis, impotence was significantly increased after
randomization in the immediate repair group (P  .03).
Comparison of specific time periods shows that this differ-
ence was not significant at 6 or 12 months after random-
ization, but was significant from 18 months to 4 years (P
.05; Fig 2). This pattern does not reflect the difference in
rate of AAA repair between the two groups, which was
greatest in the first month after randomization and declined
steadily afterward.3 When the rate of impotence is exam-
ined in all patients who underwent repair, regardless of
randomization group, a steady increase in prevalence over
time is noted (P  .0001), without a marked increase
immediately after AAA repair (Fig 3). Fewer than 3% of
patients reported retrograde ejaculation at any time during
the study.
Overall, maximum activity level did not differ signifi-
cantly between the two randomized groups at repeated
measures analysis. However, there was a significant interac-
tion between treatment and follow-up time (P  .02)
indicating that worsening in maximum activity score was
greater in the immediate surgery group (equivalent to
crossed curves with differing slopes). In comparison be-
tween individual time points (which should be interpreted
cautiously), the two groups did not differ at any time except
6 years, when patients in the surveillance group reported
higher activity levels (P .04, Fig 4). Compared with levels
before repair in all patients who underwent repair, regard-
less of randomization group, maximum activity level de-
creased significantly over time (P  .0001; Fig 5).
DISCUSSION
In this randomized trial of patients with small asymp-
tomatic AAAs, immediate elective AAA repair and imaging
surveillance resulted in generally similar outcome in the
quality-of-life measures assessed. Immediate repair resulted
in increased impotence more than 1 year after randomiza-
tion, but was also associated with improved perception of
general health, particularly in the first 2 years.
Baseline SF36 scores for our patients are slightly lower
than for patients of similar age with very small AAA in a
randomized trial of propranolol,10 are similar to national
norms for men aged 65 years or older,6 but are higher than
scores for unselected Veterans Affairs medical center out-
patients11,12 or patients undergoing AAA repair at Brigham
and Women’s Hospital.13 Our finding that baseline SF-36
physical functioning scale was an independent predictor of
mortality is consistent with an earlier VA Cooperative
Study, in which baseline SF-36 physical component sum-
mary was an independent risk factor for death after coro-
nary artery bypass graft surgery.14
Our findings of improvement in some SF-36 scores
after repair of asymptomatic AAA, although seemingly
paradoxical, are consistent with previous studies. Two stud-
ies reported significant improvement in the SF-36 mental
Fig 4. Maximum activity level by treatment group.
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health and role—physical scales 6 months after open AAA
repair compared with preoperative levels, in addition to
improvement in bodily pain in one of the studies15 and in
the role—emotional scale in the other.13 These improve-
ments followed initial reduction in SF-36 scores 4 to 6
weeks after the procedure. The only other randomized trial
of immediate repair versus surveillance, the UK Small An-
eurysm Trial (UKSAT), reported significant improvement
in SF-20 general health and bodily pain scales 12 months
after randomization in the immediate repair group.16 The
authors of these earlier studies attributed their findings to
reduced fear of rupture15 and to relief at surviving a major
procedure,13 providing, perhaps, an empiric demonstration
of Churchill’s observation that “Nothing in life is so exhil-
arating as to be shot at without result.”17Another factor
that may have contributed to higher quality-of-life scores in
the surgery group in our study and in earlier studies is the
selective early removal of frail patients from the surgery
group as a result of operative death, as was suggested after
the UKSAT.18 Our results could also be affected by loss of
patients from later death.
The improvements documented in our study and in
earlier studies are also consistent with the previously de-
scribed “placebo effect” of surgery. In 1958 Dimond et al19
reported marked improvement in angina and exercise tol-
erance after sham coronary artery bypass graft surgery.
More recently Fischer et al20 observed that patients retro-
spectively reported improvement in disability after arthro-
plasty, although serial measurements revealed worsening
(in our study, improvements were seen in serial measures).
However, of 87 patients interviewed after elective open
AAA repair, one third reported a decrease in functional
status, and the same proportion said they had not fully
recovered from surgery after a mean of 34 months.21
Our findings suggest that, while elective open AAA
repair may cause impotence, this outcome may occur less
often and more gradually than previously believed. Retro-
spective surveys have reported rates of new impotence in
more than 80% of men with previously normal function
who underwent open AAA repair,22,23 but are subject to
recall and response bias. Magee et al24 surveyed men before
and after AAA repair, and found new impotence in 31 of
119 (26%) with previously normal function, but there was
no control group who did not undergo repair for compar-
ison. The findings of these uncontrolled studies have been
cited as reason to favor endovascular over open repair.25
However, our findings suggest that the small increase in
impotence immediately after open AAA repair may reflect
little more than background increase in impotence over
time in this population (Fig 3). Open repair appears to
cause a moderate increase in late impotence (Fig 2), though
why this would occur is not clear. Impotence is one of the
outcomes being assessed in an ongoing VA Cooperative
Study comparing open with endovascular AAA repair.
Fig 5. Maximum activity level in all study patients who underwent AAA repair.
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Our study was limited almost entirely to men, and the
results may not apply to women with AAA. A second
limitation is that our findings on impotence and maximum
activity level were each based on a single question designed
for use in this study. Questionnaires designed to assess
erectile dysfunction have been developed,26 but were not
available when our study was begun. Also, this report is of
secondary trial outcomes and involves multiple compari-
sons; thus some marginal P values, particularly for compar-
isons of individual time points, may represent chance alone.
P values were presented unadjusted because determining
precise numbers of relevant comparisons is problematic and
adjustment itself is controversial.27
We previously reported that immediate repair of AAA
less than 5.5 cm does not improve survival. We report here
that immediate repair results in quality of life scores similar
to those obtained with surveillance, although late impo-
tence is somewhat more common and perception of gen-
eral health is transiently improved.
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